“ Therapy for HER2-positive gastric cancer: an overview of the molecular and genetic characteristics of the signaling pathway, the results of clinical trials”., Вопр. онкол., vol. 69, no. 1, pp. 45–54, Mar. 2023, doi: 10.37469/0507-3758-2023-69-1-45-54.